September 02, 2025

New Bruton’s Tyrosine Kinase Inhibitor Improves Platelet Response

The FDA has approved rilzabrutinib (Wayrilz) as the first Bruton’s tyrosine kinase inhibitor for adults with chronic or persistent immune thrombocytopenia who have had an insufficient response to prior therapy.

Conexiant

September 02, 2025

Pediatric Sepsis Outcomes by EBV Serostatus

Patients who were Epstein-Barr virus seropositive showed higher levels of immune dysregulation markers.

Conexiant

September 02, 2025

Bile Acid Biomarker Stratifies HBV Cirrhosis

Antiviral therapy lowers taurochenodeoxycholic acid concentrations in patients with hepatitis B virus cirrhosis, reflecting changes in bile acid balance with viral suppression.

Conexiant

September 02, 2025

Does In-Source Fragmentation Require a Soft Touch?

Soft ionization can allow chromatography to disentangle artifacts from genuine metabolic features, argues Plasmion’s Jan-Christoph Wolf

The Analytical Scientist

August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

Can a Shingles Vaccine Shield the Heart?

New research suggests herpes zoster vaccination may offer unexpected cardiovascular protection beyond preventing painful skin outbreaks.

Conexiant

August 28, 2025

Girl With Waterdrop-Like Papules: What’s Your Diagnosis?

A teenager with atopic dermatitis presented with several painless, flesh-colored papules limited to the trunk. Dermoscopy and biopsy show selective loss of elastic fibers after prior molluscum contagiosum. What’s your diagnosis?

Conexiant

August 28, 2025

The Surprising Origins of Pathology – and the Future No One Saw Coming

How historical figures shaped modern diagnostics – and how their spirit lives on in today’s innovators

The Pathologist

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant